Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.27
13.95
-7.68
-55.05%
Share Warrants & Outstandings
Total Reserve
4.76
9.11
-4.35
-47.75%
Shareholder's Funds
11.04
23.06
-12.02
-52.12%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.26
0.00
2.26
0.00%
Secured Loans
0.80
0.00
0.80
0.00%
Unsecured Loans
1.45
0.00
1.45
0.00%
Deferred Tax Assets / Liabilities
-0.02
0.09
-0.11
-122.22%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.39
0.09
2.30
2,555.56%
Current Liabilities
Trade Payables
5.97
1.39
4.58
329.50%
Other Current Liabilities
3.70
0.61
3.09
506.56%
Short Term Borrowings
5.00
2.57
2.43
94.55%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
14.67
4.57
10.10
221.01%
Total Liabilities
28.10
27.73
0.37
1.33%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.10
9.39
-8.29
-88.29%
Less: Accumulated Depreciation
0.14
8.11
-7.97
-98.27%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.96
1.28
-0.32
-25.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
1.57
-1.57
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
5.06
-5.06
-100.00%
Other Non Current Assets
0.00
7.26
-7.26
-100.00%
Total Non-Current Assets
0.96
15.17
-14.21
-93.67%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.72
4.41
-3.69
-83.67%
Sundry Debtors
24.55
6.31
18.24
289.06%
Cash and Bank
0.20
0.06
0.14
233.33%
Other Current Assets
0.14
1.08
-0.94
-87.04%
Short Term Loans and Advances
1.55
0.70
0.85
121.43%
Total Current Assets
27.15
12.56
14.59
116.16%
Net Current Assets (Including Current Investments)
12.47
7.99
4.48
56.07%
Total Current Assets Excluding Current Investments
27.15
12.56
14.59
116.16%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.10
27.73
0.37
1.33%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.26
2.57
4.69
182.49%
Book Value per share (adjusted)
17.60
16.53
1.07
6.47%
Annual - Borrowings
Borrowings 7.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024






